
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia
Michael H. Kramer, Qiang Zhang, Robert W. Sprung, et al.
Blood (2022) Vol. 140, Iss. 13, pp. 1533-1548
Open Access | Times Cited: 62
Michael H. Kramer, Qiang Zhang, Robert W. Sprung, et al.
Blood (2022) Vol. 140, Iss. 13, pp. 1533-1548
Open Access | Times Cited: 62
Showing 1-25 of 62 citing articles:
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 111
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 111
JAK/STAT in leukemia: a clinical update
Dong Liang, Qiao-Li Wang, Wenbiao Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
Dong Liang, Qiao-Li Wang, Wenbiao Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
Isabel Weinhäuser, Diego A. Pereira‐Martins, Luciana Yamamoto Almeida, et al.
Science Advances (2023) Vol. 9, Iss. 15
Open Access | Times Cited: 23
Isabel Weinhäuser, Diego A. Pereira‐Martins, Luciana Yamamoto Almeida, et al.
Science Advances (2023) Vol. 9, Iss. 15
Open Access | Times Cited: 23
Omics approaches: Role in acute myeloid leukemia biomarker discovery and therapy
Fatemeh Sadat Shafiei, Saeid Abroun, Sadaf Vahdat, et al.
Cancer Genetics (2025) Vol. 292-293, pp. 14-26
Closed Access | Times Cited: 1
Fatemeh Sadat Shafiei, Saeid Abroun, Sadaf Vahdat, et al.
Cancer Genetics (2025) Vol. 292-293, pp. 14-26
Closed Access | Times Cited: 1
Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia
Shangyu Hou, Junya Liu, Yinghui Zhu
Cell investigation. (2025) Vol. 1, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 1
Shangyu Hou, Junya Liu, Yinghui Zhu
Cell investigation. (2025) Vol. 1, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 1
FLT3-TKD in the prognosis of patients with acute myeloid leukemia: A meta-analysis
Shuping Li, Na Li, Yun Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Shuping Li, Na Li, Yun Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 20
Immunotherapeutic targeting of surfaceome heterogeneity in AML
Marie-Ève Bordeleau, Éric Audemard, Arnaud Métois, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114260-114260
Open Access | Times Cited: 6
Marie-Ève Bordeleau, Éric Audemard, Arnaud Métois, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114260-114260
Open Access | Times Cited: 6
Application of omics in the diagnosis, prognosis, and treatment of acute myeloid leukemia
Zhiyu Zhang, Jiayi Huang, Zhibo Zhang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Zhiyu Zhang, Jiayi Huang, Zhibo Zhang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
Svea Stratmann, Mattias Vesterlund, Husen M. Umer, et al.
Leukemia (2022) Vol. 37, Iss. 3, pp. 550-559
Open Access | Times Cited: 23
Svea Stratmann, Mattias Vesterlund, Husen M. Umer, et al.
Leukemia (2022) Vol. 37, Iss. 3, pp. 550-559
Open Access | Times Cited: 23
Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine
Pedro Casado, Pedro R. Cutillas
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 4, pp. 100517-100517
Open Access | Times Cited: 15
Pedro Casado, Pedro R. Cutillas
Molecular & Cellular Proteomics (2023) Vol. 22, Iss. 4, pp. 100517-100517
Open Access | Times Cited: 15
Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia
James C. Pino, Camilo Posso, Sunil K. Joshi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101359-101359
Open Access | Times Cited: 4
James C. Pino, Camilo Posso, Sunil K. Joshi, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 1, pp. 101359-101359
Open Access | Times Cited: 4
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Yasuo Kubota, Xiaorong Gu, Laila Terkawi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
An atlas of protein-protein associations of human tissues prioritizes candidate disease genes
Diederik S. Laman Trip, Marc van Oostrum, Danish Memon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Diederik S. Laman Trip, Marc van Oostrum, Danish Memon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
EPSD 2.0: An Updated Database of Protein Phosphorylation Sites across Eukaryotic Species
Miaomiao Chen, Yujie Gou, Lei Ming, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Miaomiao Chen, Yujie Gou, Lei Ming, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia
Tim Kong, Angelo B. A. Laranjeira, Christopher T. Letson, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Tim Kong, Angelo B. A. Laranjeira, Christopher T. Letson, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia
Elissa Tjahjono, Megan R. Daneman, Bernadetta Meika, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Elissa Tjahjono, Megan R. Daneman, Bernadetta Meika, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Advancements in proteogenomics for preclinical targeted cancer therapy research
Yuying Suo, Yuanli Song, Yuqiu Wang, et al.
Biophysics Reports (2025) Vol. 11, Iss. 1, pp. 56-56
Open Access
Yuying Suo, Yuanli Song, Yuqiu Wang, et al.
Biophysics Reports (2025) Vol. 11, Iss. 1, pp. 56-56
Open Access
Integrated Computational Analysis Reveals Early Genetic and Epigenetic AML Susceptibility Biomarkers in Benzene-Exposed Workers
Silvia Vivarelli, Çiğdem Sevim, Federica Giambò, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1138-1138
Open Access
Silvia Vivarelli, Çiğdem Sevim, Federica Giambò, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1138-1138
Open Access
Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value
Yang Song, Zhe Wang, Guangji Zhang, et al.
Molecular Oncology (2025)
Open Access
Yang Song, Zhe Wang, Guangji Zhang, et al.
Molecular Oncology (2025)
Open Access
Proteomic Comparison of Acute Myeloid Leukemia Cells and Normal CD34+ Bone Marrow Cells: Studies of Leukemia Cell Differentiation and Regulation of Iron Metabolism/Ferroptosis
Frode Selheim, Elise Aasebø, Håkon Reikvam, et al.
Proteomes (2025) Vol. 13, Iss. 1, pp. 11-11
Open Access
Frode Selheim, Elise Aasebø, Håkon Reikvam, et al.
Proteomes (2025) Vol. 13, Iss. 1, pp. 11-11
Open Access
Multi-omics integration reveals immune hallmarks and biomarkers associated with FLT3 inhibitor sensitivity in FLT3-mutated AML
Mingming Niu, Ning Wang, Dandan Yang, et al.
Blood Science (2025) Vol. 7, Iss. 2, pp. e00227-e00227
Open Access
Mingming Niu, Ning Wang, Dandan Yang, et al.
Blood Science (2025) Vol. 7, Iss. 2, pp. e00227-e00227
Open Access
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy
Breanna DiAndreth, Pavlo A. Nesterenko, Aaron Winters, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Breanna DiAndreth, Pavlo A. Nesterenko, Aaron Winters, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Xiaona Zhu, Zhi‐Gang She, Qian Yang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 11
Xiaona Zhu, Zhi‐Gang She, Qian Yang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 11
Mitochondrial regulation of GPX4 inhibition–mediated ferroptosis in acute myeloid leukemia
Hiroki Akiyama, Ran Zhao, Lauren B. Ostermann, et al.
Leukemia (2023) Vol. 38, Iss. 4, pp. 729-740
Open Access | Times Cited: 10
Hiroki Akiyama, Ran Zhao, Lauren B. Ostermann, et al.
Leukemia (2023) Vol. 38, Iss. 4, pp. 729-740
Open Access | Times Cited: 10
Deciphering the functional landscape of phosphosites with deep neural network
Zhongjie Liang, Tonghai Liu, Qi Li, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113048-113048
Open Access | Times Cited: 9
Zhongjie Liang, Tonghai Liu, Qi Li, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113048-113048
Open Access | Times Cited: 9